01 1Macleods Pharmaceuticals Limited
01 1RABEPRAZOLE SODIUM
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-27
Pay. Date : 2013-09-20
DMF Number : 25711
Submission : 2012-02-18
Status : Active
Type : II
20
Macleods Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RABEPRAZOLE SODIUM, with a corresponding US DMF Number 25711.
Remarkably, this DMF maintains an Active status since its submission on February 18, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 27, 2013, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
